A detailed history of Charles Schwab Investment Management Inc transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 256,991 shares of SGHT stock, worth $927,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares
256,991
Previous 255,118 0.73%
Holding current value
$927,737
Previous $1.7 Million 4.82%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.49 - $8.31 $10,282 - $15,564
1,873 Added 0.73%
256,991 $1.62 Million
Q2 2024

Aug 12, 2024

BUY
$5.13 - $7.15 $176,631 - $246,181
34,431 Added 15.6%
255,118 $1.7 Million
Q1 2024

May 08, 2024

BUY
$4.02 - $5.89 $95,398 - $139,775
23,731 Added 12.05%
220,687 $1.17 Million
Q4 2023

Feb 06, 2024

SELL
$1.29 - $5.86 $38,026 - $172,741
-29,478 Reduced 13.02%
196,956 $1.02 Million
Q3 2023

Nov 08, 2023

BUY
$2.88 - $8.8 $115,513 - $352,959
40,109 Added 21.53%
226,434 $763,000
Q2 2023

Aug 09, 2023

BUY
$7.46 - $10.67 $9,168 - $13,113
1,229 Added 0.66%
186,325 $1.54 Million
Q1 2023

May 11, 2023

BUY
$8.44 - $13.35 $13,731 - $21,720
1,627 Added 0.89%
185,096 $1.62 Million
Q4 2022

Feb 13, 2023

BUY
$5.58 - $13.94 $18,547 - $46,336
3,324 Added 1.85%
183,469 $2.24 Million
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $532,719 - $996,446
87,331 Added 94.09%
180,145 $1.14 Million
Q2 2022

Aug 15, 2022

SELL
$6.61 - $11.99 $62,510 - $113,389
-9,457 Reduced 9.25%
92,814 $835,000
Q1 2022

May 13, 2022

BUY
$11.56 - $17.9 $309,218 - $478,807
26,749 Added 35.42%
102,271 $1.18 Million
Q4 2021

Feb 11, 2022

BUY
$17.36 - $27.36 $16,353 - $25,773
942 Added 1.26%
75,522 $1.33 Million
Q3 2021

Nov 16, 2021

BUY
$22.34 - $39.1 $1.67 Million - $2.92 Million
74,580 New
74,580 $1.69 Million

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $173M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.